Evaluation of the Eversense Continuous Glucose Monitoring System in Type I Diabetic Youth

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
Self Care
Interventions
DEVICE

Eversense Continuous Glucose Monitoring

The Eversense Continuous Glucose Monitoring System is a glucose monitoring device intended to continually measure interstitial fluid glucose levels in individuals with diabetes for the operating life of the sensor.The System comprises a sensor and a transmitter. The small sensor will be subcutaneously inserted in the arm.The transmitter reads glucose data from the subcutaneous sensor.

Trial Locations (1)

30173

Kinder- und Jugendkrankenhaus AUF DER BULT, Hanover

All Listed Sponsors
collaborator

Senseonics, Inc.

INDUSTRY

lead

Kinderkrankenhaus auf der Bult

OTHER

NCT03815552 - Evaluation of the Eversense Continuous Glucose Monitoring System in Type I Diabetic Youth | Biotech Hunter | Biotech Hunter